Experts say the Food and Drug Administration’s real-world evidence framework makes clear the agency’s willingness to collaborate with groups on RWE and real-world data, according to an InsideHealthPolicy report.
However, one lawyer says, per the report, the framework is ultimately a workplan. Stakeholders will have to adapt to how the federal agency implements policies.
The FDA released the framework Dec. 6.
Click here to read the full report. (Paid subscription required)